CV Sciences, Inc. (OTCQB:CVSI) has confirmed it will disclose its financial outcomes for the second quarter ended June 30, 2026. This announcement is scheduled for August 13, 2026, after the stock market closes.
On the same day, CV Sciences will host a conference call at 1:30 PM Pacific Time (4:30 PM Eastern Time) specifically for investors and stakeholders. The call will provide insights into the company’s performance and future outlook.
Investors can participate in the call by dialing (877) 407-0784 for U.S. callers or (201) 689-8560 for international participants. Additionally, a webcast of the conference call will be available on the company’s Investor Relations page, allowing broader access to the event. A recording of the call will be accessible approximately two hours after its conclusion and will remain available until August 20, 2026.
CV Sciences emphasizes its position in the consumer wellness market, particularly known for its +PlusCBD™ brand, which is recognized as the leading hemp-extract brand in the natural products sector, according to SPINS—a key analytics provider in the industry. The company also offers non-cannabinoid supplements under the +PlusHLTH™ brand and various plant-based food products through its Cultured Foods™ brand, catering to diverse dietary needs.
As the company prepares to reveal its financial results, CV Sciences has included a disclaimer regarding forward-looking statements in its announcement. The potential results may be influenced by various risks and uncertainties affecting future performance. Stakeholders are reminded to consider these factors as they navigate investment decisions.
CV Sciences, Inc. (OTCQB:CVSI) is scheduled to announce its second quarter 2026 financial results on August 13, 2026, after the stock market closes.
The conference call for investors will take place on August 13, 2026, at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time). This call will discuss the company's financial results and provide insights for stakeholders.
Investors can participate in the conference call by dialing (877) 407-0784 from the U.S. or (201) 689-8560 for international callers. They can also access a webcast of the call, which will be available on the Company’s Investor Relations website.
A telephone replay of the conference call will be available approximately two hours after the call concludes, lasting until August 20, 2026. Investors can access this replay using the designated phone numbers and confirmation code provided.
CV Sciences, Inc. offers a range of products including hemp extracts under the +PlusCBD™ brand, non-cannabinoid supplements through +PlusHLTH™, and plant-based food products under the Cultured Foods™ brand. Their products cater to various consumer health and dietary preferences.
CV Sciences, Inc. has primary offices and facilities located in San Diego, California, Grand Junction, Colorado, and Warsaw, Poland.
According to SPINS, a leading provider of market insights, the +PlusCBD™ brand is identified as the top-selling hemp-extract brand in the natural products market, reflecting its competitive position.
The forward-looking statements in the press release are subject to risks and uncertainties that could affect the Company's future performance. Investors are advised to consider these risks and not to place undue reliance on such statements.